Embase for drug analytics

Biomedical literature has a critical role in post-market surveillance and vigilance to ensure the safety and effectiveness of drugs and medical devices. In the meantime, data extracted from the literature is being more used in different stages of drug discovery and development to achieve different goals. Understanding the relationship between drug-disease, drug-drug, device-disease and device-device can provide important insights for drug development and re-positioning.

In this webinar, Quality Control Scientist Dr. Erin van Buel will discuss

  • Indexing principles and relationships identified with in-depth indexing in Embase
  • How to use advanced search filters and features to identify semantic relationships between drugs and diseases, such as drugs used to treat a disease, drug-drug combination, drug-drug interaction, etc.
  • How the semantic relationships identified with in-depth indexing can be used to inform drug development, re-positioning and safety

Related whitepapers, case studies, etc.

Elsevier's Life Science Solutions,Computer Programs for Semi-Automation of Evidence Synthesis

Dr. Farhad Shokraneh, Research Fellow School of Medicine, University of Nottingham

10 June 2020

View webinar

Chemistry Data for Systems Thinkers

Paul Dockerty

26 May 2020

View webinar

Addressing Questions & Unmet Needs in Melanoma Research and Treatment

Marc Hurlbert; Tom Williams

19 May 2020

View webinar


Webinars that may also interest you

Scopus,Researchers: CiteScore 2019 and the responsible use of metrics

Hans Zijlstra (Research Metrics Product Manager) and Aileen Christensen (Senior Marketing Manager)

15 June 2020

View webinar

The many helpful applications of journal impact metrics

Hans Zijlstra (Product Manager, Research Metrics) and Aileen Christensen (Senior Marketing Manager)

12 June 2020

View webinar

Options to provide remote access to Elsevier platforms and tools: EDT

Rose L’Huillier, Meshna Koren

29 April 2020

View webinar